FDA’s Top-Four Tablet Scoring Concerns To Get Advisory Committee Review

The Advisory Committee for Pharmaceutical Science and Clinical Pharmacology will vote on some aspects of FDA’s draft scoring guidance, potentially giving generic industry a clue of future agency actions.

The generic industry should have a better indication Aug. 9 of where FDA stands and could go on the subject of tablet scoring.

Members of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology will consider a number of potential tablet coring requirements...